HIV infection is blocked in vitro by recombinant soluble CD4. - Wikidata - thesis-toulmin - TriplyDB

HIV infection is blocked in vitro by recombinant soluble CD4.

HIV infection is blocked in vitro by recombinant soluble CD4.

http://www.wikidata.org/entity/Q34681034

about

CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion Neutralization of poliovirus by cell receptors expressed in insect cells The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6 Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA CD4 and its role in infection of rabbit cell lines by human immunodeficiency virus type 1 Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents.Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain.Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.Soluble receptor-induced retroviral infection of receptor-deficient cells Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.Quantifying the infectivity of human immunodeficiency virus.Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.Gene therapy for infectious diseases HIV proteins in normal human placentae.An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells.Competition between solution and cell surface receptors for ligand. Dissociation of hapten bound to surface antibody in the presence of solution antibody.Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block fusion-active gp41 core formation.Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D CD4-Pseudomonas exotoxin conjugates delay but do not fully inhibit human immunodeficiency virus replication in lymphocytes in vitro.Cell-surface expression and purification of human CD4 produced in baculovirus-infected insect cells.CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.Soluble receptor potentiates receptor-independent infection by murine coronavirus.

P2860

Q24559959-A4C480C3-61D6-4DBF-869F-56CAB41A42BC Q24655726-ACEB6E28-7109-4DF3-9542-DC69033BAA72 Q24685965-A76515CE-CFC2-4DEB-A2F3-F6C588021943 Q27469855-33EE8A38-95B8-4276-AEA0-FD24D3A5E521 Q27486549-D7C627A6-1C16-4316-AD2B-B7DBAF1D2C94 Q28323307-4255B24A-37FB-4410-8200-2F3B5D3085C6 Q28340298-7C444AC1-0C18-4E17-BB98-DCB911095DB7 Q28359667-4410DC29-4A16-4A7F-A56D-266D4189F3D2 Q28379084-311B5068-B830-4E8F-8373-39C04F4394B4 Q28478188-34A25720-1FE7-4EE2-B9EA-B87DECCE9532 Q31076336-0E1F30CC-2441-4F5A-B781-54CC7B074644 Q33558696-5FB160E0-F323-446B-8A55-D6C2BBCDFB93 Q33584112-A594D6CF-065E-4DC2-89EB-7BFFEBB05EEF Q33641132-22979205-1E19-4325-A2E1-03A372571B59 Q33644217-A331E0F9-B137-47F7-90B2-B0C0A17058DF Q33682284-3990D7A4-B38A-447E-854D-9014B53A76B0 Q33760671-60AC742A-1883-40A3-B27F-2B09E588D07C Q33780620-39D36CDC-5EAF-4C5E-A79C-6819A326B924 Q33782608-1858CF6B-95F1-4A63-A4D1-B56399C88A5E Q33795266-DC842C44-1FE1-451C-8C4C-ECEAC99AA299 Q33807796-B8C35161-9205-4C94-8E9B-430CBE659362 Q33835427-FC959ECF-D3BC-48B2-8D76-8E78D5FF7939 Q33839485-72529E61-1E30-45F9-B1F6-8ADF93D99C3C Q33850415-0B66300B-C9F6-4FEE-9C34-0E414F743C1B Q33854208-B9E0D384-C4D6-40CD-BB0A-954B17F681F9 Q33854440-E20B21F3-A9D5-4482-B9F2-6931AFCD15FC Q33863493-BC34FD80-2137-411C-8288-313C1BB81B4B Q33936268-AE775B97-9CF9-4FA1-B67B-0A02519D6F66 Q33992464-76841830-6FCF-4DED-AB8B-34BD261428B2 Q34016689-8AEA91F6-7148-45E3-9611-24735403639C Q34064238-06EF47FC-C897-4D19-8AEA-794C39B7BC57 Q34125217-827EF290-2C09-4428-9F4E-F2BE5C891B2F Q34127619-DD9D9768-28A0-48C6-84AD-307545D7BA3E Q34151017-ED6C175A-09DF-4A7D-94CB-70CB6BFB6C81 Q34154514-CB203561-AE93-45DA-84A9-59D96BB16FD8 Q34233037-C7186488-7DC6-476A-BB95-B3AF523EABEF Q34263852-A60CE3E3-DDA6-4069-A570-4C0190D32A9D Q34310314-DB386136-F5F7-40AC-B3B8-9259D6C20E3F Q34323939-63F6FCD9-6DA9-47F7-965C-BAAAB372DFFF Q34329104-0A42DF93-62A8-4F40-A6BB-2480477A4715

P2860

HIV infection is blocked in vitro by recombinant soluble CD4.

http://www.wikidata.org/entity/Q34681034

description

1988 nî lūn-bûn

@nan

1988 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

HIV infection is blocked in vitro by recombinant soluble CD4.

@ast

HIV infection is blocked in vitro by recombinant soluble CD4.

@en

HIV infection is blocked in vitro by recombinant soluble CD4.

@nl

type

label

HIV infection is blocked in vitro by recombinant soluble CD4.

@ast

HIV infection is blocked in vitro by recombinant soluble CD4.

@en

HIV infection is blocked in vitro by recombinant soluble CD4.

@nl

prefLabel

HIV infection is blocked in vitro by recombinant soluble CD4.

@ast

HIV infection is blocked in vitro by recombinant soluble CD4.

@en

HIV infection is blocked in vitro by recombinant soluble CD4.

@nl

P1433

Q34681034-1D475A17-A599-466E-BF33-D6C20597683B

P1476

Q34681034-F4933A40-EF2D-4D44-B090-DCEFA5926C24

P2093

Q34681034-2D405759-133F-44FA-800E-9567C68944AC

Q34681034-3381201F-C485-400B-9BC4-CFC364D9F4EB

Q34681034-5023C7E3-EDC7-42E1-A3D9-CC8AF44DD59A

Q34681034-801D3852-3B7F-4A91-ACEE-EAF665126DB8

Q34681034-86539450-905E-4760-9C5F-6C7F28FB53BC

Q34681034-A3803F58-2534-478D-9788-5C8F3C801E2A

Q34681034-A4E03797-A583-4DFB-B047-CA3D1F53E76C

Q34681034-C6F4F3C4-3D86-4F9C-96F3-34738D64EDFD

Q34681034-D3EEABBB-FFE7-4899-85B4-41C17EF4ACD7

Q34681034-F19572E0-862A-4B4E-8F72-A58F6663338B

P2888

Q34681034-16434EE5-08A1-486E-ADA3-84D7119EED7C

P304

Q34681034-94B7016A-B147-4A90-8EF7-488353249753

P31

Q34681034-E796E0EA-57C3-469D-96B3-424B9844F0A0

P356

Q34681034-A9092A5A-EAC8-45A1-8F58-B52351AB01F7

P407

Q34681034-C813DA36-D98E-4C03-9E4D-E55444ED0BE2

P433

Q34681034-F3B2438F-E720-4428-8296-6FF33E21DE6D

P478

Q34681034-44676867-1ACD-4C2C-B285-B1B738D6AD1E

P577

Q34681034-3082FD23-2D27-4B52-8D48-60F497CF313A

P6179

Q34681034-91644BD2-0DC3-4D55-B219-18B99EC73585

P698

Q34681034-D27D74A1-1DE9-451A-AB3C-BD81255FEEF4

P356

P1433

P1476

HIV infection is blocked in vitro by recombinant soluble CD4.

@en

P2093

Bertonis JM

http://www.w3.org/2001/XMLSchema#string

Costopoulos DS

http://www.w3.org/2001/XMLSchema#string

Fisher RA

http://www.w3.org/2001/XMLSchema#string

Hirsch MS

http://www.w3.org/2001/XMLSchema#string

Johnson VA

http://www.w3.org/2001/XMLSchema#string

Liu T

http://www.w3.org/2001/XMLSchema#string

Meier W

http://www.w3.org/2001/XMLSchema#string

Schooley RT

http://www.w3.org/2001/XMLSchema#string

Tizard R

http://www.w3.org/2001/XMLSchema#string

Walker BD

http://www.w3.org/2001/XMLSchema#string

P2888

P304

76-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/331076A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6151

http://www.w3.org/2001/XMLSchema#string

P478

331

http://www.w3.org/2001/XMLSchema#string

P577

1988-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052824432

http://www.w3.org/2001/XMLSchema#string

P698

2829022

http://www.w3.org/2001/XMLSchema#string